Literature DB >> 29346571

Natural Course of Human T-Cell Leukemia Virus Type 1 Proviral DNA Levels in Carriers During Pregnancy.

Naoki Fuchi1, Kiyonori Miura1, Takashi Tsukiyama1, Daisuke Sasaki2, Kaori Ishihara2, Kazuto Tsuruda2, Hiroo Hasegawa2, Shoko Miura1, Katsunori Yanagihara2, Hideaki Masuzaki1.   

Abstract

The measurement of human T-cell leukemia virus type 1 (HTLV-1) proviral DNA levels by using polymerase chain reaction has been beneficial for confirming HTLV-1 infection during pregnancy. However, the influence of pregnancy on HTLV-1 infection and proviral DNA levels among pregnant women with HTLV-1 has not been clarified. We prospectively gathered blood samples from 36 pregnant women in whom HTLV-1 carriage was previously diagnosed and sequentially measured their proviral DNA levels. The HTLV-1 proviral DNA levels remained at a plateau during pregnancy but were elevated after delivery. Moreover, flow cytometry and serological analyses revealed that the regulatory T-cell population and soluble interleukin 2 receptor levels were similarly elevated after birth in comparison with those in control pregnant women. This study is the first to provide data on sequential changes in HTLV-1 proviral DNA levels during and after pregnancy. These findings will guide the establishment of a better program to prevent mother-to-child transmission of HTLV-1.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29346571     DOI: 10.1093/infdis/jiy017

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  HTLV-1 targets human placental trophoblasts in seropositive pregnant women.

Authors:  Kenta Tezuka; Naoki Fuchi; Kazu Okuma; Takashi Tsukiyama; Shoko Miura; Yuri Hasegawa; Ai Nagata; Nahoko Komatsu; Hiroo Hasegawa; Daisuke Sasaki; Eita Sasaki; Takuo Mizukami; Madoka Kuramitsu; Sahoko Matsuoka; Katsunori Yanagihara; Kiyonori Miura; Isao Hamaguchi
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

2.  Pregnancy does not adversely impact diagnostic tests for HTLV-1/2 infection.

Authors:  Carolina Rosadas; Jennifer H Tosswill; Richard Tedder; Graham P Taylor
Journal:  PLoS Negl Trop Dis       Date:  2019-09-12

3.  Surveillance of Hepatitis Viruses in Several Small Islands of Japan by Ship: A Public Health Approach for Elimination of Hepatitis Viruses by 2030.

Authors:  Tomohiro Akao; Morikazu Onji; Keitarou Kawasaki; Takahide Uehara; Yukima Kuwabara; Takashi Nishimoto; Shinji Yamamoto; Jiro Miyaike; Masaki Oomoto; Teruki Miyake
Journal:  Euroasian J Hepatogastroenterol       Date:  2019 Jul-Dec

Review 4.  Role of Viral Infections in the Pathogenesis of Sjögren's Syndrome: Different Characteristics of Epstein-Barr Virus and HTLV-1.

Authors:  Hideki Nakamura; Toshimasa Shimizu; Atsushi Kawakami
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

5.  Pregnancy complicated by HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP): a case report.

Authors:  Hiroshi Mori; Eiji Shibata; Tomoichiro Kuwazuru; Takayuki Uchimura; Emi Kondo; Yukio Iwanaka; Kiyoshi Yoshino
Journal:  Clin Case Rep       Date:  2021-07-23

6.  Anti-HTLV-1/2 IgG Antibodies in the Breastmilk of Seropositive Mothers.

Authors:  Carolina Rosadas; Timothy Woo; Jana Haddow; Aileen Rowan; Graham P Taylor
Journal:  Microorganisms       Date:  2021-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.